Novonix Ltd (NVNXF)

Featured in High-Beta Stocks

NOVONIX Ltd is an Australian company listed on OTC Markets as common stock under the symbol NVNX.F. The business focuses on battery technology and materials, with operations organized across Battery Materials, Battery Technology, and Graphite Exploration. Its activities include developing and producing battery anode materials and cell testing equipment, conducting research and development in battery applications, and providing consulting services. The company also manages, maintains, and develops the Mount Dromedary natural graphite deposit in Northern Queensland, Australia. NOVONIX serves customers in battery manufacturing, materials, automotive original equipment manufacturing, and consumer electronics. Founded in 2012 and formerly known as Graphitecorp Limited, the company adopted its current name in July 2017 and is based in Brisbane, Australia.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-NVNX.F
$0.17
67.1% Upside
Bargain
Weak
0.0%
August 20, 2026
-1.1x
0.6x
18.5x
100.9 M
125.6 M
48.0%
85.1%
-0.7
110.4%
Valuation • Fair Value

Novonix Ltd (OTC-NVNX.F) Fair Value by Valuation Model

Compare the primary fair value estimate for Novonix Ltd (OTC-NVNX.F) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$0.17

Estimated upside of 67.1% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$0.17

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Novonix Ltd (OTC-NVNX.F) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Novonix Ltd (OTC-NVNX.F)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

5.617 M

Current operating scale indicator.

Revenue Forecast

3.281 M

Forward revenue estimate.

EBITDA

-48.316 M

Current operating profitability reference.

EBITDA Forecast

-25.212 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Novonix Ltd (OTC-NVNX.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Novonix Ltd (OTC-NVNX.F)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

2

Weak quality score that deserves closer review.

Beneish M-Score

-3.33

No elevated caution signal from this screen.

Altman Z-Score

-0.7

Lower score that deserves closer risk review.

FCF / Net Income

110.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Novonix Ltd (OTC-NVNX.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Novonix Ltd (OTC-NVNX.F)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 20, 2026

Days to Earnings

30

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Novonix Ltd (OTC-NVNX.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Novonix Ltd (OTC-NVNX.F) Stock Forecast & Technical Outlook

Review Novonix Ltd (OTC-NVNX.F) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Novonix Ltd (OTC-NVNX.F) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Novonix Ltd (OTC-NVNX.F) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Novonix Ltd (OTC-NVNX.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Novonix Ltd (OTC-NVNX.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Novonix Ltd (OTC-NVNX.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Novonix Ltd (OTC-NVNX.F)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Novonix Ltd (OTC-NVNX.F) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ Fast Investor Answers

Novonix Ltd (OTC-NVNX.F) Stock FAQ

Quick answers about Novonix Ltd (OTC-NVNX.F) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$0.17
Estimated upside 67.1%
Valuation Rating
Undervalued
Estimated upside of 67.1%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Weak
Current financial-health read

The current fair value estimate for Novonix Ltd (OTC-NVNX.F) is $0.17. This implies an estimated upside of 67.1% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 67.1% versus the current market price.

An analyst price target for Novonix Ltd (OTC-NVNX.F) is not currently available in the latest data file.

The current financial health read for Novonix Ltd (OTC-NVNX.F) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Novonix Ltd (OTC-NVNX.F) is August 20, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Novonix Ltd (OTC-NVNX.F) is -1.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Novonix Ltd is 100.9 M.

The current enterprise value listed for Novonix Ltd is 125.6 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Novonix Ltd is OTC-NVNX.F, and the stock is listed on OTC Markets.

Novonix Ltd (OTC-NVNX.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Novonix Ltd is 48.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Novonix Ltd is 85.1%. Free float helps investors understand how much of the share base is available for public trading.